Shopping Cart
- Remove All
- Your shopping cart is currently empty
FTX-6746 is an orally active and selective PPARG reverse inhibitor with anticancer activity. It can be used in research on urothelial carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.206 € | 6-8 weeks | |
50 mg | 1.567 € | 6-8 weeks | |
100 mg | 2.375 € | 6-8 weeks |
Description | FTX-6746 is an orally active and selective PPARG reverse inhibitor with anticancer activity. It can be used in research on urothelial carcinoma. |
In vivo | In mouse UMUC9 or HT1197 xenograft models, FTX-6746 significantly inhibited tumor growth by oral administration (doses of 3-60 mg/kg twice daily for 21 days). [1] |
Alias | FX909, FX 909, FTX6746 |
Molecular Weight | 316.69 |
Formula | C16H7ClF2N2O |
Cas No. | 2829349-96-2 |
Smiles | N#CC=1C=CC(Cl)=C(C1)C2=CC(=O)C=3C(F)=CC(F)=CC3N2 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (94.73 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.